Adelman, Daniel C,Silverman, Jeffrey A,Satoshi, Nakao,Masaru, Higaki
申请号：
NO20150466
公开号：
NO339613B1
申请日:
2015.04.17
申请国别(地区):
NO
年份:
2017
代理人:
摘要：
The present invention relates to a compound which is (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in treating a hematologic cancer, wherein the compound is prepared to be administered in a dose of 60 mg/m 2 - 110 mg/m 2 .
